These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 9151916

  • 1. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
    Nakamura S, Tanaka K.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
    [Abstract] [Full Text] [Related]

  • 2. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
    Tateishi H, Oi H, Masuda N, Yano H, Matsui S, Kinuta M, Maruyama H, Yayoi E, Okamura J.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma.
    Koda M, Okamoto K, Miyoshi Y, Kato S, Murawaki Y, Horie Y, Suou T, Kawasaki H.
    Hepatogastroenterology; 1994 Feb; 41(1):25-9. PubMed ID: 8175109
    [Abstract] [Full Text] [Related]

  • 4. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H.
    Hepatogastroenterology; 2001 Feb; 48(41):1409-15. PubMed ID: 11677976
    [Abstract] [Full Text] [Related]

  • 5. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S, Tani M, Okamura J, Ogawa M, Ohashi Y, Monden M, Hayashi S, Inoue J, Kawarada Y, Kusano M, Kubo Y, Kuroda C, Sakata Y, Shimamura Y, Jinno K, Takahashi A, Takayasu K, Tamura K, Nagasue N, Nakanishi Y, Makino M, Masuzawa M, Yumoto Y, Mori T, Oda T.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [Abstract] [Full Text] [Related]

  • 6. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M, Suzuki H, Yamamoto T, Mamada Y, Mizuno H, Tominaga T, Suga M, Suemori S, Kato Y, Sato A, Yamanouchi E, Sakuyama K, Maeyama S, Shinagawa T, Okabe K.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma.
    Yamamoto K, Masuzawa M, Kato M, Kurosawa K, Kaneko A, Ishida H, Imamura E, Park NJ, Shirai Y, Fujimoto K, Michida T, Hayashi N, Ikeda M.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-50-S6-55. PubMed ID: 9151917
    [Abstract] [Full Text] [Related]

  • 8. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK.
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [Abstract] [Full Text] [Related]

  • 9. [Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma].
    Tateishi H, Hasuike Y, Kinuta M, Furukawa J, Takata N, Maruyama H, Oi H, Yayoi E, Okamura J.
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1492-4. PubMed ID: 8396903
    [Abstract] [Full Text] [Related]

  • 10. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y, Balkanci F, Kayhan B, Uzunalimoglu B, Gokoz A, Ozisik Y, Gurakar A, Van Thiel DH, Firat D.
    Hepatogastroenterology; 1996 Aug; 43(9):681-7. PubMed ID: 8799415
    [Abstract] [Full Text] [Related]

  • 11. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization.
    Tanaka K, Nakamura S, Numata K, Okazaki H, Endo O, Inoue S, Takamura Y, Sugiyama M, Ohaki Y.
    Radiology; 1992 Nov; 185(2):457-60. PubMed ID: 1329143
    [Abstract] [Full Text] [Related]

  • 12. Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.
    Ishii H, Okada S, Sato T, Nose H, Okusaka T, Yoshimori M, Takayasu K, Takayama T, Kosuge T, Yamasaki S.
    Hepatogastroenterology; 1996 Nov; 43(9):644-50. PubMed ID: 8799409
    [Abstract] [Full Text] [Related]

  • 13. Combined therapy with external beam irradiation and hepatic arterial epirubicin infusion through an implanted port for advanced hepatocellular carcinoma.
    Takizawa K, Honda M, Obuchi M, Hasebe S, Matsuoka S, Yamada M, Kuniyasu Y.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-116-S6-121. PubMed ID: 9151926
    [Abstract] [Full Text] [Related]

  • 14. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy.
    Kotoh K, Sakai H, Sakamoto S, Nakayama S, Satoh M, Morotomi I, Nawata H.
    Am J Gastroenterol; 1994 Feb; 89(2):194-8. PubMed ID: 8304302
    [Abstract] [Full Text] [Related]

  • 15. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 16. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T, Ikeda M, Okusaka T, Ueno H, Morizane C, Ogura T, Hagihara A, Iwasa S.
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [Abstract] [Full Text] [Related]

  • 17. Treatment of large hepatocellular carcinoma: comparison between techniques and long term results.
    Ferrari FS, Stella A, Gambacorta D, Magnolfi F, Fantozzi F, Pasquinucci P, Civeli L, Pieraccini M.
    Radiol Med; 2004 Oct; 108(4):356-71. PubMed ID: 15525889
    [Abstract] [Full Text] [Related]

  • 18. [Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system].
    Morimoto M, Numata K, Sugimori K, Shirato K, Kokawa A, Oka H, Hirao M, Hirasawa K, Ko R, Saitou T, Imada T, Tanaka K.
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1592-5. PubMed ID: 16315880
    [Abstract] [Full Text] [Related]

  • 19. Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma.
    Itsubo M, Koike K, Tsuno S, Osada M, Komuro O, Shimada N, Okuda J, Fukada H, Okuaki Y, Kawabe T, Toda G.
    Hepatogastroenterology; 2002 Oct; 49(45):735-9. PubMed ID: 12063981
    [Abstract] [Full Text] [Related]

  • 20. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis.
    Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, Saito S, Kiba T, Okazaki H, Sekihara H.
    Cancer; 1998 Jan 01; 82(1):78-85. PubMed ID: 9428482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.